litlas
ログインアカウント作成

Robert G. Uzzo

1991–2025 年に発表

別表記
Robert G. UZZO
178
論文数
29,045
被引用数
92
h 指数
169
i10 指数

被引用数

Robert G. Uzzo の年別被引用数1986 年: 被引用 1 件1992 年: 被引用 3 件1993 年: 被引用 1 件1996 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 6 件1999 年: 被引用 10 件2000 年: 被引用 27 件2001 年: 被引用 35 件2002 年: 被引用 33 件2003 年: 被引用 32 件2004 年: 被引用 62 件2005 年: 被引用 75 件2006 年: 被引用 92 件2007 年: 被引用 102 件2008 年: 被引用 106 件2009 年: 被引用 84 件2010 年: 被引用 126 件2011 年: 被引用 186 件2012 年: 被引用 184 件2013 年: 被引用 135 件2014 年: 被引用 140 件2015 年: 被引用 163 件2016 年: 被引用 147 件2017 年: 被引用 125 件2018 年: 被引用 204 件2019 年: 被引用 682 件2020 年: 被引用 828 件2021 年: 被引用 724 件2022 年: 被引用 578 件2023 年: 被引用 474 件2024 年: 被引用 828 件2025 年: 被引用 344 件2026 年: 被引用 16 件1987〜1991 年は被引用が無いため表示していません1994〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,293 件、この内訳の 27.8%中国: 引用元論文 809 件、この内訳の 9.8%イタリア: 引用元論文 617 件、この内訳の 7.5%イギリス: 引用元論文 432 件、この内訳の 5.3%ドイツ: 引用元論文 374 件、この内訳の 4.6%フランス: 引用元論文 364 件、この内訳の 4.4%カナダ: 引用元論文 357 件、この内訳の 4.3%日本: 引用元論文 249 件、この内訳の 3%オランダ: 引用元論文 224 件、この内訳の 2.7%スペイン: 引用元論文 221 件、この内訳の 2.7%オーストラリア: 引用元論文 180 件、この内訳の 2.2%ベルギー: 引用元論文 156 件、この内訳の 1.9%
0%27.8%その他 23.8%

機関

分野

  • Medicine74.5%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Immunology and Microbiology2.4%
  • Pharmacology, Toxicology and Pharmaceutics1.8%
  • Engineering1.7%
  • Nursing1.5%
  • その他4.4%

トピック

  • Renal cell carcinoma treatment13.8%
  • Bladder and Urothelial Cancer Treatments6.4%
  • Renal and related cancers4.8%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Prostate Cancer Diagnosis and Treatment2.7%
  • Prostate Cancer Treatment and Research2.3%
  • その他67.3%

共著者

全論文

検索で開く
  1. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I

    著者: Steven C. Campbell, Peter E. Clark, Sam S. Chang, José A. Karam, Lesley Souter, Robert G. Uzzo - The Journal of Urology 2021 被引用: 725

  2. The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth

    著者: Alexander Kutikov, Robert G. Uzzo - The Journal of Urology 2009 被引用: 2,374

  3. Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies

    著者: Peter Makhov, Shreyas Joshi, Pooja Ghatalia, Alexander Kutikov, Robert G. Uzzo, Vladimir Kolenko - Molecular Cancer Therapeutics 2018 被引用: 565

  4. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial

    著者: Sumanta K. Pal, Robert G. Uzzo, José A. Karam, Viraj A. Master, Frede Donskov, Cristina Suárez, Laurence Albigès, Brian I. Rini, Yoshihiko Tomita, Ariel Galapo Kann, Giuseppe Procopio, Francesco Massari, Matthew R. Zibelman, I. Antonyan, Mahrukh Huseni, Debasmita Basu, Bo Ci, William Leung, Omara Khan, Sarita Dubey, Axel Bex - The Lancet 2022 被引用: 230

  5. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II

    著者: Steven C. Campbell, Robert G. Uzzo, José A. Karam, Sam S. Chang, Peter E. Clark, Lesley Souter - The Journal of Urology 2021 被引用: 254

  6. Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work

    著者: Steven R. Austin, Yu‐Ning Wong, Robert G. Uzzo, J. Robert Beck, Brian L. Egleston - Medical Care 2013 被引用: 718

  7. Renal Mass and Localized Renal Cancer: AUA Guideline

    著者: Steven C. Campbell, Robert G. Uzzo, Mohamad E. Allaf, Eric B Bass, Jeffrey A. Cadeddu, Anthony Chang, Peter E. Clark, Brian J. Davis, Ithaar Derweesh, Leo Giambarresi, Debra A. Gervais, Susie L. Hu, Brian R. Lane, Bradley C. Leibovich, Philip M. Pierorazio - The Journal of Urology 2017 被引用: 1,240

  8. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

    著者: Naomi B. Haas, Judith Manola, Robert G. Uzzo, Keith T. Flaherty, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Michael B. Atkins, Michael Pins, George Wilding, David Cella, Lynne I. Wagner, Surena F. Matin, Timothy M. Kuzel, Wade J. Sexton, Yu-Ning Wong, Toni K. Choueiri, Роберто Пили, Igor Puzanov, Manish Kohli, Walter M. Stadler, Michael A. Carducci, Robert Coomes, Robert S. DiPaola - The Lancet 2016 被引用: 638

  9. Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    著者: Merry Jennifer Markham, KERRI WACHTER, Neeraj Agarwal, Monica M. Bertagnolli, Susan M. Chang, William Dale, Catherine Diefenbach, Carlos Rodríguez‐Galindo, Daniel J. George, Timothy D. Gilligan, R. Donald Harvey, Melissa L. Johnson, Randall J. Kimple, Miriam A. Knoll, Noelle K. LoConte, Robert G. Maki, Jane Meisel, Jeffrey A. Meyerhardt, Nathan A. Pennell, Gabrielle B. Rocque, Michael S. Sabel, Richard L. Schilsky, Bryan J. Schneider, William D. Tap, Robert G. Uzzo, Shannon N. Westin - Journal of Clinical Oncology 2020 被引用: 169

  10. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline

    著者: Antonio Finelli, Nofisat Ismaila, Bill Bro, Jeremy C. Durack, Scott Eggener, Andrew Evans, Inderbir S. Gill, David L. Graham, William C. Huang, Michael A.S. Jewett, Sheron Latcha, William T. Lowrance, Mitchell H. Rosner, Bobby Shayegan, R. Houston Thompson, Robert G. Uzzo, Paul Russo - Journal of Clinical Oncology 2017 被引用: 376

  11. Zinc and zinc transporters in prostate carcinogenesis

    著者: Vladimir Kolenko, Ervin Teper, Alexander Kutikov, Robert G. Uzzo - Nature Reviews Urology 2013 被引用: 184

  12. Circulating kidney injury molecule-1 (KIM-1) biomarker analysis in IMmotion010: A randomized phase 3 study of adjuvant (adj) atezolizumab (atezo) vs placebo (pbo) in patients (pts) with renal cell carcinoma (RCC) at increased risk of recurrence after resection.

    著者: Laurence Albigès, Axel Bex, Cristina Suárez, Robert G. Uzzo, Xiaobin Tang, Zoe J. Assaf, Sarita Dubey, Erik T. Goluboff, Corey Carter, Romain Banchereau, Mahrukh A Huseni, Sumanta K. Pal, Brian I. Rini - Journal of Clinical Oncology 2024 被引用: 49

  13. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation

    著者: Andres Correa, Opeyemi A. Jegede, Naomi B. Haas, Keith T. Flaherty, Michael R. Pins, Edward M. Messing, Judith Manola, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Robert S. DiPaola, Michael A. Carducci, Robert G. Uzzo - Journal of Clinical Oncology 2019 被引用: 153

  14. Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial

    著者: Chaitanya Divgi, Robert G. Uzzo, Constantine Gatsonis, Roman Bartz, Silke Treutner, Jian Q. Yu, David Chen, Jorge A. Carrasquillo, Steven M. Larson, Paul Bevan, Paul Russo - Journal of Clinical Oncology 2012 被引用: 258

  15. Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence

    著者: Janusz Franco‐Barraza, Ralph Francescone, Tiffany Luong, Neelima Shah, Raj Madhani, Gil Cukierman, Essel Dulaimi, Karthik Devarajan, Brian L. Egleston, Émmanuelle Nicolas, R. Katherine Alpaugh, Ruchi Malik, Robert G. Uzzo, John P. Hoffman, Erica A. Golemis, Edna Cukierman - eLife 2017 被引用: 107

  16. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer

    著者: Sonali M. Smith, KERRI WACHTER, Howard A. Burris, Richard L. Schilsky, Daniel J. George, Douglas E. Peterson, Melissa L. Johnson, Merry Jennifer Markham, Kathryn F. Mileham, Muhammad Shaalan Beg, Johanna C. Bendell, Robert Dreicer, Vicki L. Keedy, Randall J. Kimple, Miriam A. Knoll, Noelle K. LoConte, Helen Mackay, Jane Meisel, Timothy J. Moynihan, Daniel A. Mulrooney, Therese M. Mulvey, Olatoyosi Odenike, Nathan A. Pennell, Katherine E. Reeder‐Hayes, Cardinale B. Smith, Ryan J. Sullivan, Robert G. Uzzo - Journal of Clinical Oncology 2021 被引用: 97

  17. Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma

    著者: Robert A. Figlin, Nizar M. Tannir, Robert G. Uzzo, Scott S. Tykodi, David Y.T. Chen, Viraj A. Master, Anil Kapoor, Daniel A. Vaena, William T. Lowrance, Gennady Bratslavsky, Mark DeBenedette, Alicia Gamble, Ana Plachco, Marcus S. Norris, Joe Horvatinovich, Irina Y. Tcherepanova, Charles A. Nicolette, Christopher G. Wood - Clinical Cancer Research 2020 被引用: 78

  18. Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon–degrading Bacteria Among Bladder Cancer Patients

    著者: Laura Bukavina, Ilaha Isali, Rashida Ginwala, Mohit Sindhani, Adam Calaway, Diana Magee, Benjamin Miron, Andres Correa, Alexander Kutikov, Matthew R. Zibelman, Mahmoud A. Ghannoum, Mauricio Retuerto, Lee Ponsky, Sarah C. Markt, Robert G. Uzzo, Philip H. Abbosh - European Urology Oncology 2023 被引用: 48

  19. Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

    著者: Mohamad E. Allaf, Se-Eun Kim, Viraj A. Master, David H. McDermott, Lauren C. Harshman, Suzanne Cole, Charles G. Drake, Sabina Signoretti, Mahmut Akgül, Nicholas Baniak, Elsa M. Li-Ning, Matthew B. Palmer, Hamid Emamekhoo, Nabil Adra, Hristos Z. Kaimakliotis, Yasser Ged, Phillip M. Pierorazio, E. Jason Abel, Mehmet Asım Bilen, Kenneth Ogan, Helen Moon, Krishna Ramaswamy, Eric A. Singer, Tina Mayer, Jay Lohrey, Vitaly Margulis, Jessie Gills, Scott E. Delacroix, Mark J. Waples, Andrew James, Peng Wang, Toni K. Choueiri, M. Dror Michaelson, Anil Kapoor, Daniel Y.C. Heng, Brian Shuch, Bradley C. Leibovich, Primo N. Lara, Judith Manola, Deborah Maskens, Dena Battle, Robert G. Uzzo, Gennady Bratslavsky, Naomi B. Haas, Michael A. Carducci - The Lancet Oncology 2024 被引用: 82

  20. Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805)

    著者: Wenxin Xu, Mäneka Puligandla, Brian Halbert, Naomi B. Haas, Keith T. Flaherty, Robert G. Uzzo, Janice P. Dutcher, Robert S. DiPaola, Venkata Sabbisetti, Rupal S. Bhatt - Clinical Cancer Research 2021 被引用: 45

  21. Guideline for Management of the Clinical T1 Renal Mass

    著者: Steven C. Campbell, Andrew C. Novick, Arie S. Belldegrun, Michael L. Blute, George K. Chow, Ithaar Derweesh, Martha M. Faraday, Jihad Kaouk, Raymond J. Leveillee, Surena F. Matin, Paul Russo, Robert G. Uzzo - The Journal of Urology 2009 被引用: 1,841

  22. Small renal masses progressing to metastases under active surveillance

    著者: Marc C. Smaldone, Alexander Kutikov, Brian L. Egleston, Daniel Canter, Rosalia Viterbo, David Y.T. Chen, Michael A.S. Jewett, Richard E. Greenberg, Robert G. Uzzo - Cancer 2011 被引用: 405

  23. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy

    著者: Tobias Klatte, Vincenzo Ficarra, Christian Gratzke, Jihad Kaouk, Alexander Kutikov, Veronica Macchi, Alexandre Mottrie, F. Porpiglia, James Porter, Craig Rogers, Paul Russo, R. Houston Thompson, Robert G. Uzzo, Christopher G. Wood, Inderbir S. Gill - European Urology 2015 被引用: 286

  24. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

    著者: Тимур Митин, Daniel Hunt, William U. Shipley, Donald S. Kaufman, Robert G. Uzzo, Chin‐Lee Wu, Mark K. Buyyounouski, Howard M. Sandler, Anthony L. Zietman - The Lancet Oncology 2013 被引用: 159